Page last updated: 2024-09-04

gadofosveset trisodium and Kidney Diseases

gadofosveset trisodium has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE	1

Other Studies

1 other study(ies) available for gadofosveset trisodium and Kidney Diseases

Article	Year
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:3 Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors	2010

Article

Year

Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.

Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:3

Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors

2010